Progressive Fibrosing Interstitial Lung Diseases clinical trials

Explore recruiting progressive fibrosing interstitial lung diseases clinical trials.

Recruiting progressive fibrosing interstitial lung diseases studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Progressive Fibrosing Interstitial Lung Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis

Netherlands, Czechia, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

Netherlands, Greece, Slovenia, Germany, Hungary, France +13 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Progressive Fibrosing Interstitial Lung Diseases trials by city

Progressive Fibrosing Interstitial Lung Diseases in Toronto Progressive Fibrosing Interstitial Lung Diseases in Vancouver Progressive Fibrosing Interstitial Lung Diseases in Montreal Progressive Fibrosing Interstitial Lung Diseases in Calgary Progressive Fibrosing Interstitial Lung Diseases in Edmonton Progressive Fibrosing Interstitial Lung Diseases in Ottawa Progressive Fibrosing Interstitial Lung Diseases in Winnipeg Progressive Fibrosing Interstitial Lung Diseases in Quebec City Progressive Fibrosing Interstitial Lung Diseases in Hamilton Progressive Fibrosing Interstitial Lung Diseases in Kitchener Progressive Fibrosing Interstitial Lung Diseases in London Progressive Fibrosing Interstitial Lung Diseases in Halifax Progressive Fibrosing Interstitial Lung Diseases in New York Progressive Fibrosing Interstitial Lung Diseases in Los Angeles Progressive Fibrosing Interstitial Lung Diseases in Chicago Progressive Fibrosing Interstitial Lung Diseases in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease